Ohad is a Partner at Pontifax, where he is in charge of scouting and evaluation. He joined the fund in 2009 and currently serves as board member of Agomab, Eyevensys, Metabomed, Pi Tx and Kamari. Ohad obtained his M.S. in Biology from Tel-Aviv University.
Your browser is not supported. Update your browser for more security, speed and to make the most of this site.